Wednesday, January 27, 2010

Plastic and Reconstructive Surgery

Plastic and Reconstructive Surgery

PLASTIC SURGERY
Plastic Surgery (Greek plassein = to Mould) is concerned with the restoration of form and function of the human body”

Plastic and Reconstructive Surgery
1              Soft Tissue Management
2              Trauma
3              Hand Surgery
4              Neoplasia
5              Breast Reconstruction
6              Congenital including Cleft  Surgery
7              Aesthetic Surgery
8              Burns

Patient Examination
Describe wound, shape,  measurements
Haemorrhage, foreign bodies,  surrounding tissue damage
Document Neurovascular  injuries
Radiology
Microbiology

Soft Tissue  Management - Reconstructive Ladder
1. Primary Closure
2. Secondary Intention
3. Skin Graft
  • Split thickness
  • Full thickness
4. Local Tissue Flaps
5. Distant Tissue Flaps
6. Free Tissue Flaps


TRAUMA

Upper Limb
  • Musculoskeletal
  • Neurovascular
  • Hand Fractures
Lower Limb
Facial Lacerations
Trunk
Burns
2. Trauma
Follow ATLS principles
Treat as Appropiate e.g.

Wound Management - Debridement
< 6 Hours if possible
Second look 48 hours later
Classification of wounds
  • Clean  (elective, no GI, GU, Trauma)
  • Clean contaminated (Minor breaks of sterility)
  • Contaminated (Traumatic, spillage, infected bone or tissue)
  • Dirty (abscess, soft tissue infection)

Scar Management
Normal
Hypertrophic
Keloid

Upper Limb
  • Vascularity
  • Neurology
  • Tendons
  • Muscle Bellies
  • Bones
  • Foreign bodies
Flexor Tenosynovitis
Kanavel’s Cardinal Signs
  • Fusiform Swelling
  • Pain on passive extension
  • Tenderness over flexor tendon sheath
  • Flexed digital posture

Replantation of Amputated Limbs/Digits
  • Mechanism: Sharp/Blunt
  • Condition of Amputated Stump
  • Timing since Injury
  • Indication for Attempted  Replantation

Transportation of Amputated Parts
  • Wrap Amputated Part in Moist  Saline Gauze
  • Place in Watertight Container
  • Place in another Sealed  Container of Iced Water
  • Place Patient ID on Container

Facial Lacerations
  • Important structures
  • Human bites
  • Innoculation risk for HIV and Hepatitis
  • Difficult reconstructive problem

Lower Limb Trauma
Gustillo and Anderson Classification of Tibial Fractures
I              Soft tissue wound < 1 cm
II              Soft tissue wound > 1 cm,  without extensive soft tissue  damage
III              Soft tissue damage requiring  reconstruction
    • A              Adequate soft tissue coverage
    • B              Soft tissue loss with periosteal  stripping and bone exposure
    • C              Vascular Injury

Hand Surgery
  • Trauma
  • Reconstructive
  • Congenital
  • Degenerative

Dupuytrens Disease
Characterised by fibrosis & contracture of the palmar fascia result = digital contracture
Solitary / multiple painless nodules, skin dimpling & flexion contractures
Associations
  • Alcoholism
  • Diabetes Mellitus
  • Epilepsy
  • Smoking
  • Chronic Pulmonary Disease
  • HIV
  • ?? Manual labour

Treatment = Surgery
Palmar Fasciectomy
  • Partial or Complete
  • Care with skin flaps
Dermatofasciectomy- Severe, diathesis, recurrent  disease


Neoplasia
  • BCC
  • SCC
  • Melanoma
  • Others
Inspection
Site
Size
Shape
Surface/Edge – sloping, raise  rolled, undermined
Base – slough, granulation  tissue, discharge
Surround
Palpate
Temperature
Tenderness
Consistency
Mobility
Pulsation
Fluctuation
Reducibility


Squamous Cell  Carcinoma
Epidermal keratinocytes
Sun induced
Immunosupression
Marjolin
HPV
70% in head and neck & 15% on upper extremities
2-6% metastatic risk
Characteristically invasive SCC
raised, firm, pink-to-flesh–coloured keratotic papule or plaque arising on sun-exposed skin
Surface changes: ulceration, crusting,cutaneous horn Less commonly, SCC may manifest as a pink cutaneous nodule without overlying surface changes.

Head & Neck Cancer
Aggressive
Usually SCC
Excision and Reconstruction can be technically demanding

Breast  Reconstruction
  • Implant Only
  • Pedicled Flap – LD Flap
  • Free Flap
  • TRAM
Congenital
  • Cleft
  • Craniofacial
  • Congenital limb
  • Skin
  • Genito-urinary
  • Cleft
  • Craniofacial
  • Congenital limb
Aesthetic Surgery
Burns

BURNS

Types: Thermal, Chemical,  Electrical.
Significant cause of morbidity  and mortality.
Acute Management
Resuscitation
Lund and Browder Chart
Parkland Formula
Assessment of Depth
Assessment of Extent

Reducing  Morbidity/Mortality
High index of suspicion for the  presence of Inhalational injury.
Maintenance of haemodynamic  normality with volume  resuscitation.
Temperature control.
Removal from injury-provoking  environment.
Primary survey (ATLS)
A - Airway
B - Breathing
C – Circulation
Airway/Breathing
Circulation
Breathing problems: 1) Direct  thermal injury. 2) Inhalation of  toxic fumes. 3) CO poisoning.
Pointers to Inhalational injury:  Hx of confinement; Coughing;  Wheeze; SOB; Facial burns;  Carbonaceous sputum.
CarboxyHb >10% → CO  poisoning.
Consider definitive airway.
H.R, B.P.,Urine output.
Burns >20% TBSA needs  circulatory volume support  (>10% in kids/elderly).
ATLS guideline: 2-4ml  Hartmanns soln per kg body wt  per % partial/full thickness burn  in the first 24 hrs.

Depth of Burn
Superficial Burns
  • E.g. sunburn.  Erythema, pain,  blanches with pressure,  absence of blisters. 3-6 days  healing time. No scarring.
Superficial Partial  Thickness Burn
  • E.g. Scald (splash).  Blisters;  moist, red and weeping;  blanches with pressure.  Painful  to air and temp.  7-20 days  healing time. Scarring unusual.
Deep Partial Thickness  Burn
  • E.g. Scald (spill).  Blisters  (easily deroofed), wet or dry,  variable colour, does not blanch  with pressure.  Perceptive of  pressure only.  Healing time  >21 days.  High risk of  contracture.
Full Thickness Burn
  • E.g. flame, steam, boiling oil,  high voltage electricity.  Waxy  white to leathery grey to  charred and black; dry; does  not blanch with pressure.     Lacks sensation. Generally  never heals.  Severe risk of  contracture.

Extent of Burn
  • Expressed as the total % body  surface area (TBSA) affected  by the burn.
  • Several methods developed to  estimate the TBSA of burns.
  • Rule of Nines (less accurate for  kids).
  • Lund and Browder method.
  • Very rough guide: Palm of  hand= 1% TBSA.

Additional issues
Analgesia
Dressings: Indicated for all  partial and full thickness burns;  Provide anaesthetic relief, act  as a barrier to infection, keep  wound dry.
Tetanus immunisation:  indicated for burns deeper than  superficial partial thickness.
Antibiotic prophylaxis not  indicated.
Special Burn  Requirements
Chemical burns- e.g. exposure to acids, alkalines, petroleum products.  Removal of chemical essential to good outcome- immediately wash away with large amounts of water for at least 20-30 min.
Electrical burns- Frequently more serious than they appear on surface (eg deep muscle necrosis). Cardiac arrythmias(48 hrs), Rhabdomyolysis (need particularly aggressive fluid therapy).
Who needs  hospitalisation?
  • >10% TBSA burn in adult (>5% in young or old).
  • >2% full thickness burn.
  • High voltage injury.
  • Suspected inhalational injury.
  • Circumferential burn.
  • Comorbidity predisposing to infection.
  • Suspected child abuse.





RECONSTRUCTION LADDER

To reconstruct
  • Skin loss
  • Fascia loss
  • Muscle loss
  • Bone loss

Types
Secondary intention healing
  • Healing through contraction  and epithelialization
Primary Closure :  approximation of edges
  • Think of typical surgical  wound
  • Decreased scar
  • Less granulation tissue
Delayed Primary Closure
  • Surgical closure within days
  • Usually occurs if wound is  contaminated
  • Wound is initially debrided  and rigourous on table  washout
  • Closed usually after 4 days
  • Eg: dog or human bite

Basic Techniques
Defect analysis
  • Volume and type of tissue  missing
  • Start with earliest rung on  the ladder

Reconstruction  Ladder
The reconstructive ladder is a term coined by reconstructive plastic surgeons to describe levels of increasingly complex management of wounds
Rung 1: healing by secondary intention
Rung 2: primary closure
Rung 3: delayed primary closure
Rung 4: split thickness graft
Rung 5: full thickness skin graft
Rung 6: tissue expansion
Rung 7: random pattern flap
Rung 8: pedicled flap
Rung 9: free flap

The Ladder : Skin  Grafts
SSG
  • Epidermis and variable  dermis
  • Taken from buttock or thigh
  • Cover large areas: often  meshed 1: 1.5
  • Donor site heals excellently
  • Graft contracts+++: poor  scar
  • Takes under less favourable  conditions than FTG
  • Skin Grafts
FTGs
  • All epidermis and dermis
  • Donor site must be closed  primarily = scar
  • Cover less area
  • Useful for face: better  cosmesis
  • Less contracture
Skin Grafts : Basic  Principles
  • WILL NOT TAKE ONTO EXPOSED:
    • Bone (except membranous orbital bone)
    • Cartilage
    • Tendon
  • WILL TAKE ONTO:
    • Periostium
    • Perichondrium
    • Paratenon
  • Graft inspection: Day 5-7
  • Donor site inspection: Day 10-12

Local Tissue Transfer
AKA  Flaps
  • Have their own blood  supply
  • Constituents:
    • Skin, fascia, muscle, bone
    • Proximity to defect: local,  regional, distant
    • Movement: rotation,  advancement, transposition
Rotation Flaps
Transposition Flap

Distant tissue  Transfer
Flap still attached to its pedicle. Eg:
  • LD for breast recon
  • TRAM for breast recon
Free Flaps
  • Flap separated from its  blood supply
  • Transferred to defect and  vein and artery are  anastomosed to vessels  near site of defect
  • Most complicated rung of  ladder
  • Needs microscope or Loupe  magnification
  • Examples
    • LD
    • TRAM
    • DIEP
    • RFF
LD Flap
Possible Questions
  • Covering defects: bone,  tendon, cartilage
  • Factors that stop grafts  taking
  • Flap monitoring
  • Possible anaerobes
  • Graft and donor site  inspection

Free Flap monitoring
Can fail due to venous or  arterial insufficiency
Venous congestion signs
  • Brisk refill
  • Congested, dark
  • Bleeds black blood
Arterial insufficiency signs: Pale, cold, no pulse on  doppler, CRT slow



BASAL CELL CARCINOMA
Most common cutaneous  malignancy
Almost NEVER metastasizes
Often leads to local destruction
Usually arise from epidermis or  outer root sheath of hair follicle

Epidemiology
Most common in fair skin
Fitzpatrick types : I and II
Males > Females
Rarely found before age 40

Fitzpatrick Skin Types
Type 1
Type 2
Type 3
Type 4
Type 5
Type 6
Pale skin
Blond, red hair
Never tans
Burns easily
Tans poorly
Darker white skin
Tans after burning first
Light brown skin
Burns minimally
Tans easily
Brown skin
Tans easily
Rarely burns
Black skin
Never burns

Aetiology
Sunlight: mainly UVB
Artificial UVB: Tanning salons
Ionizing radiation
For acne treatment
Immunosuppression
Renal transplants etc
Xeroderma Pigmentosa
Autosomal recessive: inability to repair UV damaged DNA,increased risk of all skin Ca.
Other features: corneal deposits, blindness
Gorlin syndrome
Autosomal Dominant
Odontogenic keratocysts, palmoplantar pitting, intracranial calcs, rib anomalies
Aetiology
Bazex Syndrome
Features:
   -follicular atrophoderma : “ice pick hands”
   -local anhydrosis
   -multiple BCCs
Hx of previous non-melanoma skin Ca

Types of BCC
Nodular-ulcerative
  • Most common type
  • Raised, round pearly lesion
  • As it enlarges : telangiectasia  and central ulceration
  • Mainly on face
Cystic
  • Uncommon variant of nodular
  • Polypoid appearance
  • Typically blue-grey cyst
Pigmented
  • Brown - black macules in some  areas
  • Difficult to distinguish from MM
Sclerosing
  • White-yellow, waxy sclerotic  plaque
  • Increased collagen deposit  from fibroblasts- thus  resembling a scar
  • Margins are difficult to see
Superficial
  • Erythematous patch or plaque
  • Multicentric
-normal skin interspersed with  malignant patches

Investigations
Biopsy
  • Punch
  • Shave
  • Incisional
  • Excisional
  • Deep-wedge
Imaging- Not required as very little risk of  metastasis < 0.01%

Treatment
Medical
5-FU cream (Efudex)
   -T bd x 2/52
   -cure in 93% in some trials
   -surgery is preferred

Surgery
Excision
   -direct closure
   -local flap
   -FTSG ie PAWG (Wolf)
Mohs Micrographically  controlled surgery

Mohs Surgery
Tumour excised and 1mm of  surrounding tissue is examined  under microscope
Additional pieces of tumour are  removed in the persisting area
Highest cure rate: 99%
Time consuming, LA top ups  required

Recurrence
Risk factors:
  • BCC in NL fold
  • Recurrent tumours
  • Large tumours >2cm
  • Deeply infiltrating tumours
  • Young females


SQUAMOUS CELL CARCINOMA
2nd most common skin Ca
Malignant tumour of epidermal  keratinocytes
Can Metastasize
Strongly related to sun  exposure
70% occur on head and neck

Epidemiology
Age > 50
Fitzpatrick I and II
Males
Closer to equator

Aetiology
Sunlight: UVB
Sunbeds
Ionizing Radiation
Arsenic
Xeroderma Pigmentosa
Transplants: greatest in heart
HPV: 5,6,8,11,16
Chronic Ulcers: Marjolins
Burns
Necrobiotic Lipoidica
Hidradenitis
Actinic Keratosis



Bowens Disease
Intra-epidermal form of SCC
SCC in situ: BM not invaded
Well demarcated erythematous  plaque
Irregular border
Surface crusting or scaling
Rx: Photodynamic therapy,  Cryotherapy or topical 5-FU.

SCC Types
Typical: most common
Periungual
Perioral
Marjolins
Anogenital
Verrucous

Typical SCC
A raised, firm, pink-to-flesh –coloured keratotic papule or plaque arising on sun-exposed skin
70% occur on head and neck
Surface changes may include:
  • Scaling
  • Ulceration
  • Crusting

SCC Pathophysiology
malignant tumour of epidermal keratinocytes
De novo or from actinic keratoses
Capable of:
Local infiltration
Spread to regional nodes
Distant mets

Investigations
  • Biopsy
  • Incisional
  • Excisional
  • Punch- Must reach level of mid dermis  to see if invasion has occurred
If a patient has  lymphadenopathy:
  • Imaging studies: CT
  • LN biopsy or FNA
  • May require lympadenectomy  of the draining basin

Staging: AJCC
Use TNM guidelines
Most SCC are not metastatic at  time of presentation
Staging: AJCC
Classification of primary tumour:
T0: no evidence of primary
Tis: Ca in situ
T1: <2cm in greatest diameter
T2: 2-5cm in greatest diameter
T3: >5cm in greatest diameter
T4: deep invasion; bone,cartilage, muscle

Medical Care
Topical therapy
  • For premalignant and in-situ  lesions
  • Efudex (5 FU)
Topical immune response modifier
  • enhances cell-mediated immune responses via the induction of proinflammatory cytokines
  • e.g. imidazoquinoline (Imiquimod)
Radiotherapy
Indications:
   -patients refusing/not fit for  surgery
   -metastatic disease
Radiotherapy problems:
  • Expensive and time consuming
  • Irritation at site: erythema, erosions
  • Pain: requiring narcotic analgesia
  • Poor long term cosmesis: cutaneous atrophy, dyspigmentation, telangiectasia
  • Increased risk of further cutaneous malignancy

Surgery
Cryotherapy
  • Liquid nitrogen
  • For selective SCCs: AKs or Cis
  • Complications:
    • transient pain
    • oedema
    • blistering
Electrodessication and  Curettage
  • Indications; AK and Cis
  • Tumour margins are delineated  with a curette and scraped out:  tumour is far more friable than  normal tissue
  • Main disadvantage is loss of  margin
  • Cure rates of 96-99% have  been quoted
  • Surgery
Excision with conventional  margins
  • 4mm margin for low risk  lesions:<2cm, well differentiated,  without fat invasion
  • 6mm margin for higher risk  lesions:>2cm, fat invasion, high risk  areas- central face, ears,  genitalia
Mohs Micrographic Surgery
  • Excellent option if tissue  preservation is required
  • Almost 100% of histologic  margin is examined (compared  to 1% in conventional excision)
  • Best cure rates for SCC (94- 99%)
  • Local recurrences are fewer

Chemotherapy
Useful for metastatic disease
Capecitabine (Xeloda) ang IFN alpha

Prognosis
Variable:
Tumor- and patient-related risk factors associated with higher rates of recurrence and metastasis are as follows:
Tumor-related factors in high-risk SCC:
  • Location: lips, ears, scar
  • Tumour size > 2cm
  • Poorly diff tumour
  • Recurrent tumour
  • Perineural involvement
Patient-related factors in high-risk SCC
  • Organ transplant recipient
  • Haematological malignancy ie CLL
  • Chronic immunosuppression
  • HIV infection
Prognosis: Overall
  • The 3-year disease-specific survival rate is 85%
  • Almost 100% if none of previous risk factors
  • 70% if 1 risk factor present

The Future?
NSAIDS:
  • May protect against SCC  development
  • COX 2 often overexpressed in  SCC
  • Studies are ongoing



MALIGNANT MELANOMA
A malignancy of pigment  producing melanocytes
Predominantly skin
Also: eyes, ears, GI tract, and  oral and genital mucous  membranes
Accounts for 4% of skin  cancers
Responsible for 74% of all skin  cancer deaths

Frequency
6th  most common cancer in U.S.
1 in 60 lifetime risk of  developing melanoma in  Caucasians
Highest incidence in Australia  and NZ
Incidence increasing worldwide.

Epidemiology
Primarily disease of whites
Whites: African-Americans  =  20:1
MR far higher in darker skin  types
Incidence greatest in females
Mortality highest in males
Median age at Dx = 53

Aetiology/Risk factors
Changing mole
Atypical naevus
Large numbers of common naevi >100
Naevus >20cm
Previous melanoma
Sun exposure
1st degree relative
BCC/SCC
Male
>50
XP
Fitzpatrick I and II
Immunosuppression

Pathophysiology
Tumour progression: 5 stages
Benign melanocytic naevus
Dysplastic naevus: cytolological  atypia
Primary MM: radial growth  phase
Primary MM: vertical growth  phase
Metastatic MM

Classification
Superficial Spreading  Melanoma
  • Most common, accounts for  70%
  • Usually > 6mm in diameter
  • Occurs most commonly:
    • On trunk in men
    • On legs in women
  • Irregular, asymmetric borders  are characteristic
  • Histologically, characterized by  “buckshot scatter “(pagetoid) of  atypical melanocytes within the  epidermis

Nodular Melanoma
  • Second most common : 25%
  • Legs and trunk are most  common sites
  • Raised dark brown-black  papule or nodule
  • Usually lacks the ABCDE  warning signs
  • Lacks radial growth phase

Lentigo Maligna  Melanoma
  • Accounts for 4-10%
  • Most common on head, neck  and arms
  • Precursor lesion = lentigo  maligna
    • Usually present for 10-15yrs
    • Dark brown macule or patch
  • Dermal invasion characterized  by raised blue-black lesions  within precursor
  • In Australia
    • More common in men on RHS
    • More common in women on  LHS

Acral Lentiginous  Melanoma
  • Accounts for 2-4%
  • Accounts for 55% in dark skinned individuals
  • Usually occurs in glabrous skin or beneath the nail plate (subungual variant)
  • Pigment spread to the proximal or lateral nail folds is termed the Hutchinson sign
  • Characteristic features:
    • Irregular pigmentation
    • Large size > 3cm
    • Plantar location

Amelanotic Melanoma
  • Non pigmented
  • Pink or flesh coloured – often  mimicking BCC or SCC

Rare Sub-Types
  • Desmoplastic Melanoma
  • Mucosal Melanoma
  • Malignant Blue Naevus
  • Melanoma of Soft Parts (clear  cell sarcoma)


Assessment
History
Exam
  • Inspection alone can diagnose  65%
  • Nodes: axillary, cervical and  groin
MacKies 7 point checklist
  • Major (2 points each)
    • Change in size
    • Irregular pigmentation
    • Irregular outline
    • Diameter > 6mm
  • Minor (1 point each)
    • Inflammation
    • Oozing
    • Itch or altered sensation
  • Needs further evaluation in  presence of one major or if  score = 3

American ABCDE
  • A: asymmetry
  • B: border is irregular
  • C: colour variation
  • D: diameter >6mm
  • E: examine other lesions
Biopsy
  • Types
    • Incisional
    • Excisional
    • Punch
  • NB not shave
  • Information gained from biopsy:
    • Tumour depth
    • Anatomical level
    • Ulceration
    • Presence of mitoses
    • LVI
    • Host response (tumour infiltrating lymphocytes)
    • Regression
    • Immunohistochemical staining  for lineage: (S-100) or for  proliferation markers (Ki67)
  • Excisional biopsy
    • 1-3mm of normal skin should  be removed with the lesion as  more than this could disrupt  lymphatic drainage and  compromise subsequent LN  mapping

Clarkes Level
Classifies level of invasion
  • Level 1: only epidermis  involved
  • Level 2: invades part of  papillary dermis
  • Level 3: invasion fills papillary  dermis
  • Level 4: invades reticular  dermis
  • Level 5: invades subcutaneous  tissue

Breslows Thickness
  • Most important histological  determinant of prognosis
  • Measured vertically in mm
    • From top of granular layer  (base of superficial ulceration)
    • To deepest point of tumour  invasion

                                               5yr  survival
0.76mm – 1.5mm                    80%
1.5mm – 4mm                         65%
>/= 4mm                                  35%

  • Gives better indication of  prognosis: As depth (Clarkes) of papillary  and reticular dermis vary  throughout the body
Staging
AJCC- Incorporates TNM with Clarkes  and Breslow

Spread
Locally, in LN basins or distally:
  • Remote skin
  • Remote nodes
  • Viscera
  • Skeleton
  • CNS

Surgery
Excision margins;
  • 0.5 cm for melanoma in situ
  • 1cm with Breslow thickness  <2mm
  • 2cm with Breslow thickness >/=  2mm
Melanomas near vital structures  may require a reduced margin
Aggressive histological features  may necessitate a wider margin
Mohs surgery may have certain  "niche" indications- MM of face,  neck or hands

Sentinel Node Mapping
  • Growing in popularity
  • Isosulfan blue dye and  lymphoscintigraphy
  • Is it as useful as mapping in  breast Ca?
  • Sentinel Node Mapping
  • Advantages
    • If node –ve, no need for nodal  clearance
    • More thorough pathological  assessment of nodes
    • Psychological relief to patient if  node negative
    • Disadvantages
    • Poor mapping in head and neck  tumours
    • Tumour may skip SN
  • Indications: controversial
    • Patients in whom the estimated  risk of LN metastasis is at least  10%
    • Clinically node –ve patients with  tumours >/= 1mm
  • Not indicated in tumours  <0.75mm
  • 0.76-0.9mm: nebulous area

Elective LN Dissection
  • Lymphadenectomy when nodes  are clinically negative
  • Rationale is that MM spreads to  nodal basin first – so clearing  the LNs reduces risk of spread
  • Controversial: studies have  conflicting results
  • Nodal Dissection
  • Patients with palpable, clinically  +ve nodes should undergo  complete nodal dissection

Adjuvant Therapy
Interferon  α  2b
  • For high risk resected MM:
    • >4mm depth
    • Regional nodal metastases
  • Diminishes occurrence of mets
  • Prolongs disease free survival

Chemotherapy
For unresectable regional mets  or distant mets
Dacarbazine is the most active  chemotherapeutic agent

Biological Therapy
Interleukin 2
  • Useful for metastatic melanoma
  • In one study, 7% had complete  response with patients  remaining disease free for up to  8yrs
Monoclonal antibody therapy
  • Experimental but very  promising
Vaccines
  • Undergoing trials currently

Perfusion Chemo
Isolated Limb Perfusion (ILP)
  • Tourniquet applied
  • Artery and vein cannulated
  • Agent infused and removed  from circulation
  • Most effective method of Rx for  local recurrence or in-transit  metastases
  • Agents used: TNF α , melphalan

Radiotherapy
For palliation
Specific indications:
  • Brain metastases
  • Pain with bony mets
  • Superficial subcutaneous mets

Prevention
Public education- Australia: “slip, slop, slap”  campaign
Adequate clothing
Avoid UV rays
Systemic carotenoids : retinol- Useful in preventing malignant  transformation

1 comment:

Unknown said...

This is a great inspiring article.I am pretty much pleased with your good work.You put really very helpful information. Keep it up. Keep blogging. Looking to reading your next post.
Knoxville abdominoplasty

Designed by Irfan Ziad • Copyleft under Creative Commons Attribution • Watermark Template • Powered by Blogger